Tel Aviv, Israel

Rotem Sella-Erez

USPTO Granted Patents = 7 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Rotem Sella-Erez: Innovator in Pharmaceutical Sciences**

Introduction

Rotem Sella-Erez is a prominent inventor based in Tel Aviv, Israel, known for his significant contributions to the pharmaceutical industry. With a total of seven patents to his name, Sella-Erez has played a crucial role in advancing innovative medical treatments.

Latest Patents

His latest patents encompass groundbreaking work in the field of pharmaceuticals. One of his notable patents is focused on "Solid state forms of lumateperone ditosylate salt," which discloses solid state forms of this compound, along with its various uses and pharmaceutical compositions. Another significant patent involves "Crystalline polymorphs of Pracinostat and Pracinostat salts," presenting new crystalline forms of this important drug and its related pharmaceutical compositions.

Career Highlights

Sella-Erez has worked with esteemed companies in the industry, including Assia Chemical Industries Ltd. and Teva Pharmaceuticals International GmbH. His experience in these organizations has allowed him to leverage his innovative ideas and translate them into actionable pharmaceutical solutions.

Collaborations

Throughout his career, Rotem Sella-Erez has collaborated with talented professionals, including Ariel Mittelman and Sharona Shachan-Tov. These partnerships have further enriched his research and development efforts, leading to successful outcomes in his projects.

Conclusion

Rotem Sella-Erez's contributions to pharmaceutical sciences, evidenced by his patents and collaborations, highlight his commitment to advancing medical innovation. His work continues to impact the industry, positioning him as a valuable asset in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…